Skip to Main Content

Paper Details

Association Between a 22-feature Genomic Classifier and Biopsy Gleason Upgrade During Active Surveillance for Prostate Cancer.
Eur Urol Open Sci
11
2022
22-feature Genomic Classifier, GG1, GG2 disease, Prostate Cancer, patients, prostate cancer
Author NameAffiliation
Daniel W LinUniversity of Washington
Daniel W LinFred Hutchinson Cancer Research Center
Burcu F DarstUniversity of Southern California Center for Genetic Epidemiology, Keck School of Medicine
Burcu F DarstUniversity of Southern California Center for Genetic Epidemiology, Keck School of Medicine
John S WitteStanford University
  • 1 - 5

Datasets

Release 1.2